Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

LabConnect Helps Sponsors Streamline Trials With Launch of Data Integration Services

Posted on: 30 Nov 16

LabConnect, a leading provider of highly customized global central laboratory and early development services to biopharmaceutical, medical device and contract research organizations, has announced the launch of its data integration services, which help sponsors coordinate complex, high-volume data collection and management from multiple laboratories’ data sources.

LabConnect’s enhanced, comprehensive data management capabilities streamline clinical trials by developing an infrastructure and coordinating logistics for programming, coding, cleaning and conditioning data that comes from a variety of sources.

By mapping and assembling the disparate data sources, standardizing data formats and merging, LabConnect provides superior data consistency, accuracy and usability. These outsourced solutions save sponsor resources and are particularly useful for delivering cohesive data for clinical projects, especially where timelines can be challenging.

“LabConnect’s robust data management services and tools provide sponsors improved speed, quality and continuity in their data,” said Eric Hayashi, president and CEO. “Data quality is ensured and documentation approved by the sponsor. We can often provide these services to our clients at a lower cost and with a faster turnaround than they can achieve keeping the tasks in-house, allowing them to remain focused on the core objectives of their clinical innovation.”

For more information about data integration and additional service areas, visit

About LabConnect, LLC
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, biorepository and scientific support services for biopharmaceutical, medical device and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory and early development service needs, from preclinical through Phase IV. Learn more at or connect with LabConnect on LinkedIn.

View source version on

Business Wire

Last updated on: 30/11/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.